Skip to main content
Article
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma
Annals of Surgery (2012)
  • Sojun Hoshimoto, Saint John's Health Center
  • Mark B. Faries, Saint John's Health Center
  • Donald L. Morton, Saint John's Health Center
  • Tatsushi Shingai, Saint John's Health Center
  • Christine Kuo, Saint John's Health Center
  • He Jing Wang, University of California, Los Angeles
  • Robert Elashoff, University of California, Los Angeles
  • Nicola Mozzillo, Istituto Nazionale per lo Studio e la Cura dei Tumori Giovanni Pascale
  • Mark C. Kelley, Vanderbilt University
  • John F. Thompson, Royal Prince Alfred Hospital
  • Jeffrey E. Lee, Surgical Oncology
  • Dave S.B. Hoon
Publication Date
February 1, 2012
DOI
10.1097/SLA.0b013e3182380f56
Citation Information
Sojun Hoshimoto, Mark B. Faries, Donald L. Morton, Tatsushi Shingai, et al.. "Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma" Annals of Surgery Vol. 255 Iss. 2 (2012) p. 357 - 362
Available at: http://works.bepress.com/dave-hoon/140/